More Life in Action: Our 2026 AGM Business Update
Thank you to everyone who joined us for yesterday’s 2026 Annual General Meeting for MLCO.
By Dennis H.

Thank you to everyone who joined us for yesterday’s Annual General Meeting. I appreciated the opportunity to bring our business together in one presentation and share the progress, priorities and ambition behind The More Life Company.
This year’s presentation was an important opportunity to show how our work across Agriculture and Human Health connects to a clear commercial strategy. There is considerable depth behind our technologies, and I wanted shareholders to see both the opportunities immediately in front of us and the larger markets we are intentionally pursuing.
Among the areas we covered:
Agrarius commercialization
Spiros shared how our extensive field validation and relationships with leading researchers, agronomists and growers are supporting active sales discussions across priority crops in Latin America.
Quicksome and U.S. compounding
We discussed the commercial pathway we are advancing for our delivery technology, with opportunities across hormones, sexual health and other pharmaceutical applications.
Broader pharmaceutical opportunities
We outlined why we are pursuing applications across GLP therapies and other important therapeutic areas where formulation and delivery challenges can limit what a medicine can achieve.
Our growth objectives
We shared the scale of business we are working to build and how our commercial priorities connect to those ambitions.
Building meaningful, repeatable revenue is central to our work. We are concentrating our efforts where the science, customer need and commercial relationships give us the strongest opportunities to convert progress into business. At the same time, we are pursuing partnerships that could bring our technologies into much larger markets.
On a personal level, it was especially meaningful to share this update under The More Life Company name. It brings together the purpose behind our work: helping biology perform better, whether that means more productive farmland or making valuable medicines easier for people to access and take.
I hope you will make time to watch the presentation. It provides a much fuller picture of what we are building and why I remain confident in our direction.
Thank you to our team, advisors and partners for the work they do every day, and to our shareholders for your continued support and engagement.
Life has more to give. We are committed to helping unlock it.